Trade group KEFEA claims picture on medicine prices distorted

Constant references to “expensive” medicines and wrongful comparisons between the private sector drug prices in Cyprus and prices of other countries with comprehensive health systems, paint a distorted picture of medicine prices in Cyprus, says the Cyprus Association of Research and Development Pharmaceutical Companies (KEFEA).

The pharma trade group has denounced this attempt to mislead the public and explains that the pricing policy is defined by the state and there are no margins for profiteering by the pharmaceutical companies, as it has been implied.

Commenting on statements by Auditor General Chrystalla Georghadji at the House Committee on Development Plans and Public Expenditure Control that she had received threats due to her assertions on high medicine prices, as well as the reference by DIKO Member of Parliament  Georgios Prokopiou that he too had been subjected to interventions on the same topic, KEFEA is calling on the two officials to submit specific evidence, so as to avoid stigmatizing persons and companies.